Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,248) Arrow Down
Filter Results: (1,248) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,248)
    • People  (5)
    • News  (172)
    • Research  (929)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (759)

Show Results For

  • All HBS Web  (1,248)
    • People  (5)
    • News  (172)
    • Research  (929)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (759)
← Page 60 of 1,248 Results →
  • 2014
  • Working Paper

Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms

By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Read Now
Related
Choudhury, Prithwiraj, and Tarun Khanna. "Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms." Harvard Business School Working Paper, No. 14-081, February 2014.
  • September 1996
  • Case

Food and Drug Administration: Business as Unusual at CDER

By: Steven C. Wheelwright and James Leonard
Keywords: Government Administration; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Find at Harvard
Related
Wheelwright, Steven C., and James Leonard. "Food and Drug Administration: Business as Unusual at CDER." Harvard Business School Case 697-022, September 1996.
  • November 1998
  • Case

Wegmans Food Markets: Diabetes Counseling

By: Ray A. Goldberg, David E. Bell and Ann Leamon
Danny Wegman, president of Wegmans Food Markets, is trying to decide how to evaluate the success of a nutrition-counseling program for diabetics, and whether and how to expand the program beyond the two stores currently involved. Wegmans, with 57 stores and $2.3... View Details
Keywords: Performance Evaluation; Expansion; Programs; Human Needs; Financial Management; Health Care and Treatment; Nutrition; Consumer Behavior; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Goldberg, Ray A., David E. Bell, and Ann Leamon. "Wegmans Food Markets: Diabetes Counseling." Harvard Business School Case 599-057, November 1998.
  • 06 Mar 2012
  • First Look

First Look: March 6

century. It focuses especially on Beiersdorf, a pharmaceutical and skin care company in Germany. During World War I, the expropriation of its brands and trademarks revealed its vulnerability to political risk. Following the advent of the... View Details
Keywords: Sean Silverthorne
  • 13 Jun 2005
  • Research & Ideas

From Turf Wars to Learning Curves: How Hospitals Adopt New Technology

in many cases, perform identical procedures in two or more hospitals during the course of a given week. We have found that this movement has negative effects on the degree to which surgeons are able to leverage their prior experience to improve future performance. We... View Details
Keywords: by Sara Grant; Health
  • 03 Mar 2009
  • First Look

First Look: March 3, 2009

pharmaceutical division and a diagnostic division. The company's antiviral drug Tamiflu dominates the market for prevention and treatment of seasonal influenza (flu). Tamiflu, however, could also play an important role in responding to... View Details
Keywords: Martha Lagace
  • 11 Nov 2015
  • Working Paper Summaries

Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules

Keywords: by Danielle Li; Pharmaceutical; Pharmaceutical; Pharmaceutical; Pharmaceutical
  • September 2003 (Revised January 2004)
  • Case

PolyMedica Corporation (B)

By: David F. Hawkins and Jacob Cohen
Supplements the (A) case. View Details
Keywords: Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Hawkins, David F., and Jacob Cohen. "PolyMedica Corporation (B)." Harvard Business School Case 104-031, September 2003. (Revised January 2004.)
  • 19 Jan 2023
  • News

Forged in Fire

Novartis as a boy, being in an iron lung for a year. He learned he wanted to be a great doctor and then he wanted to use those doctors' gifts to help other people with pharmaceuticals that could save lives. And he did just that. But he... View Details
  • 12 Apr 2010
  • Research & Ideas

One Report: Better Strategy through Integrated Reporting

electronics company Philips; the Danish pharmaceutical company Novo Nordisk; the Brazilian cosmetics company Natura; and the U.S.-based technology and aerospace company United Technologies all come to mind. All have done a very good job... View Details
Keywords: by Martha Lagace
  • 13 Jun 2017
  • First Look

First Look at New Research and Ideas, June 13

Efforts Pay Off? Dynamic Panel Data Methods Revisited By: Chung, Doug J., Byungyeon Kim, and Byoung Park Abstract—We estimate a sales response model to evaluate the short- and long-term value of pharmaceutical sales representatives'... View Details
Keywords: Sean Silverthorne
  • 15 Dec 2014
  • Research & Ideas

Deconstructing the Price Tag

expenses incurred. For example, R&D expenditures in the pharmaceutical industry involve more than just the cost of producing one particular drug. Many drugs may have to fail before one succeeds, and that one hit drug ends up... View Details
Keywords: by Dina Gerdeman; Retail
  • 24 Sep 2007
  • Research & Ideas

The FDA: What Will the Next 100 Years Bring?

food, medicine, or cosmetics you use. Consumers would end up restricting what they buy to a few trusted brands. In effect, the FDA has made competition possible in consumer products and even in pharmaceuticals (particularly through the... View Details
Keywords: by Sean Silverthorne; Biotechnology; Consumer Products; Food & Beverage; Health
  • 13 Jan 2009
  • First Look

First Look: January 13, 2009

and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Martha Lagace
  • July 1981 (Revised December 1984)
  • Case

American Distilling Co. (B)

By: William E. Fruhan Jr.
Keywords: Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Find at Harvard
Related
Fruhan, William E., Jr. "American Distilling Co. (B)." Harvard Business School Case 281-009, July 1981. (Revised December 1984.)
  • 10 Jan 2005
  • Research & Ideas

Motivation and the Cross-Sector Alliance

medicines. Furthermore, Chile offers no reimbursements for pharmaceutical expenses, so this tends to add to customers' negative disposition." To respond to this situation, FASA considered a possible collaboration with the Fundación... View Details
Keywords: by James Austin, Ezequiel Reficco & SEKN research team
  • December 2021
  • Case

Zoetis

By: David E. Bell, Damien McLoughlin and Natalie Kindred
Keywords: Strategy; Food; Change Management; Leadership; Diversity; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Bell, David E., Damien McLoughlin, and Natalie Kindred. "Zoetis." Harvard Business School Case 522-041, December 2021.
  • 05 May 2015
  • First Look

First Look: May 5

methodology using a novel dataset developed with the division of a large pharmaceutical firm. The dataset consists of all components in the enterprise architecture, the observed dependencies between them, and estimated costs of change for... View Details
Keywords: Carmen Nobel
  • 03 Jan 2007
  • First Look

First Look: January 3, 2007

analysts from Gradient Analytics and Banc of America face charges of stock price manipulation from Biovail, a Canadian pharmaceutical company. Gradient and BofA produced negative reports on Biovail's earnings quality. At the same time,... View Details
Keywords: Sean Silverthorne
  • 07 Jun 2019
  • Book

Are You a Digital Manager?

might be working with peers in pharmaceuticals or defense to accelerate the development of virtual reality capabilities. In my work, I use the ethnographic methods of anthropology to study transformation as it takes place through shared... View Details
Keywords: by Martha Lagace
  • ←
  • 60
  • 61
  • 62
  • 63
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.